Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R; AIDS Clinical Trials Group and the Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Wheat LJ, et al. Among authors: smedema m. Clin Infect Dis. 2001 Dec 1;33(11):1910-3. doi: 10.1086/323781. Epub 2001 Oct 23. Clin Infect Dis. 2001. PMID: 11692303
Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
Connolly P, Wheat J, Schnizlein-Bick C, Durkin M, Kohler S, Smedema M, Goldberg J, Brizendine E, Loebenberg D. Connolly P, et al. Among authors: smedema m. Antimicrob Agents Chemother. 1999 Feb;43(2):322-8. doi: 10.1128/AAC.43.2.322. Antimicrob Agents Chemother. 1999. PMID: 9925526 Free PMC article.
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.
Goldman M, Cloud GA, Smedema M, LeMonte A, Connolly P, McKinsey DS, Kauffman CA, Moskovitz B, Wheat LJ. Goldman M, et al. Among authors: smedema m. Antimicrob Agents Chemother. 2000 Jun;44(6):1585-7. doi: 10.1128/AAC.44.6.1585-1587.2000. Antimicrob Agents Chemother. 2000. PMID: 10817713 Free PMC article. Clinical Trial.
Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
Connolly P, Wheat LJ, Schnizlein-Bick C, Durkin M, Kohler S, Smedema M, Goldberg J, Brizendine E, Loebenberg D. Connolly P, et al. Among authors: smedema m. Antimicrob Agents Chemother. 2000 Oct;44(10):2604-8. doi: 10.1128/AAC.44.10.2604-2608.2000. Antimicrob Agents Chemother. 2000. PMID: 10991831 Free PMC article.
19 results